Completed
Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008
NCT04770194
- Conditions
- Acute Coronary Syndrome, Brain Diseases, Cardiovascular Diseases, +7 more
- Locations
-
- Quotient Sciences Nottingham, Nottinghamshire, United Kingdom